Share on LinkedInShare on LinkedIn

ARTICLE · 08 MAY 2018

Unicorns: The Tale Continues

Proskauer Rose LLP
Proskauer Rose LLP
Contributor
Proskauer Rose LLP

Proskauer Rose LLP

Firm Overview Proskauer is an elite global law firm with more than 900 lawyers across key financial...

View firm profile
Explore more from Proskauer Rose LLP

Potential disputes involving unicorns have been a hot topic for the last several years. We predicted that would continue this year in in our webinar and related blog post ...

United StatesCorporate/Commercial Law

Potential disputes involving unicorns have been a hot topic for the last several years. We predicted that would continue this year in in our webinar and related blog post: The Top Ten Regulatory and Litigation Risks for Private Funds in 2018. In April, the Regional Director of the SEC's San Francisco office, Jina Choi, confirmed this in her comments during a San Francisco Federal Bar Association panel. Specifically, Ms. Choi discussed the SEC's actions against Zenefits, Credit Karma, and Theranos, and reiterated the SEC's continued commitment to monitoring suspected investor fraud in privately-held companies. Ms. Choi also highlighted the settlement remedies in Zenefits and Theranos, including specifically that both settlement agreements required the company and individual officers at the company to pay penalties.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from